KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Inventory: 2018-2024

Historic Inventory for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $8.1 million.

  • Castle Biosciences' Inventory rose 31.62% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 31.62%. This contributed to the annual value of $8.1 million for FY2024, which is 2.43% up from last year.
  • According to the latest figures from FY2024, Castle Biosciences' Inventory is $8.1 million, which was up 2.43% from $7.9 million recorded in FY2023.
  • Castle Biosciences' 5-year Inventory high stood at $8.1 million for FY2024, and its period low was $2.0 million during FY2021.
  • Moreover, its 3-year median value for Inventory was $7.9 million (2023), whereas its average is $6.7 million.
  • In the last 5 years, Castle Biosciences' Inventory dropped by 8.84% in 2021 and then skyrocketed by 99.55% in 2023.
  • Castle Biosciences' Inventory (Yearly) stood at $2.2 million in 2020, then declined by 8.84% to $2.0 million in 2021, then skyrocketed by 96.93% to $4.0 million in 2022, then skyrocketed by 99.55% to $7.9 million in 2023, then climbed by 2.43% to $8.1 million in 2024.